Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I C Maclennan

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Clinical and Experimental Immunology|August 1, 1986
Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgAP J Lane, I C MacLennan
BMJ (Clinical Research Ed.)|April 16, 1994
Multiple myelomaI C MacLennan, M Drayson, J Dunn
British Journal of Cancer|January 1, 1977
Effects of varying the interval between courses of methotrexate on its myelotoxic and anti-leukaemic activitiesB Harding, J Culvenor, I C MacLennan
International Journal of Cancer|June 15, 1975
Resistance of certain leukaemic myeloblasts to immunological attackI C MacLennan, D G Gale, J Wood
Immunology|January 1, 1980
Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+I C MacLennan, F M Gotch, P Golstein
European Journal of Immunology|March 1, 1988
Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zonesY J Liu, S Oldfield, I C MacLennan
British Journal of Cancer|November 1, 1977
Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiationI C MacLennan, J Peto, H E Kay
British Journal of Cancer|September 1, 1977
Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in miceS T Sonis, R Falcão, I C MacLennan
British Journal of Cancer|July 1, 1985
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosisJ Cuzick, E H Cooper, I C MacLennan
European Journal of Immunology|June 1, 1986
Virgin B cell recruitment and the lifespan of memory clones during antibody responses to 2,4-dinitrophenyl-hemocyaninD Gray, I C MacLennan, P J Lane
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Immunology|August 1, 1986
Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgAP J Lane, I C MacLennan
BMJ (Clinical Research Ed.)|April 16, 1994
Multiple myelomaI C MacLennan, M Drayson, J Dunn
British Journal of Cancer|January 1, 1977
Effects of varying the interval between courses of methotrexate on its myelotoxic and anti-leukaemic activitiesB Harding, J Culvenor, I C MacLennan
International Journal of Cancer|June 15, 1975
Resistance of certain leukaemic myeloblasts to immunological attackI C MacLennan, D G Gale, J Wood
Immunology|January 1, 1980
Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+I C MacLennan, F M Gotch, P Golstein
European Journal of Immunology|March 1, 1988
Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zonesY J Liu, S Oldfield, I C MacLennan
British Journal of Cancer|November 1, 1977
Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiationI C MacLennan, J Peto, H E Kay
British Journal of Cancer|September 1, 1977
Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in miceS T Sonis, R Falcão, I C MacLennan
British Journal of Cancer|July 1, 1985
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosisJ Cuzick, E H Cooper, I C MacLennan
European Journal of Immunology|June 1, 1986
Virgin B cell recruitment and the lifespan of memory clones during antibody responses to 2,4-dinitrophenyl-hemocyaninD Gray, I C MacLennan, P J Lane
Pageof 13